CD57+ EMRA CD8+ T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapy
Abstract Background Immune ageing complicates cancer treatment in older individuals. While immunotherapy targeting the PD-1/PD-L1 pathway can reinvigorate T cells, these cells tend to become senescent with age. This study investigates different CD8+ T cell subsets usually associated with senescence,...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-12-01
|
| Серія: | Immunity & Ageing |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12979-024-00487-4 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
